Grace Colón

Grace E.
Colón is the founder of Pyranose Biotherapeutics, founded in 2012.
Current jobs include Chairman at Bloom Science, Inc. since 2023, Director at Biotechnology Innovation Organization, Independent Director at Voyager Therapeutics, Inc. since 2023, Director at MIT Corp.
(United States), Member at Women Corporate Directors, Member at Latino Corporate Directors Association, and Trustee at Massachusetts Institute of Technology.
Former jobs include President, Chief Executive Officer & Director at InCarda Therapeutics, Inc. from 2013 to 2022; Executive Chairman at ProterixBio, Inc. from 2016 to 2023; Director at Paradigm Diagnostics, Inc. from 2017 to 2019; Director at InterLink AI, Inc. from 2015 to 2019; Director at Cocoon Biotech, Inc. from 2016 to 2020; Independent Director at CareDx, Inc. from 2019 to 2024; Vice President-Corporate Planning at Affymetrix, Inc. from 2000 to 2005; President-Industrial Products Division & SVP at Precigen, Inc. from 2010 to 2012; Head-Clinical Operations at Gilead Sciences, Inc. from 2005 to 2010 and again from 2010 to 2012; Partner at New Science Ventures LLC from 2014 to 2016; Chief Operating Officer at International Genomics Consortium from 2001 to 2002; and Engagement Manager at McKinsey & Co., Inc. from 1996 to 2000.
Education includes undergraduate studies at the University of Pennsylvania and a doctorate from the University of Massachusetts.